
The Targeted Pulse: Key Approvals, Regulatory Shifts, and ASCO Highlights
This week, the oncology landscape buzzed with significant updates, from crucial FDA decisions to groundbreaking data emerging from the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. Here's a quick recap of the top stories that …